Autoimmune pancreatitis (AIP) is characterized by persistent inflammation believed to arise from an immune system malfunction wherein the pancreas becomes the target of attack. This condition has shown positive responses to treatment with steroid therapy.
AIP has two identified types, type 1 and type 2.
Pancreatic cancer may be misdiagnosed as Type 1 AIP. It is crucial to differentiate between the two disorders because they have similar signs and symptoms but totally distinct approaches to treating them.
AIP usually do not cause any symptoms. If the symptoms present, a comprehensive investigation is necessary because the symptoms are similar to those with pancreatic cancer.
Signs and symptoms of pancreatic cancer may manifest as follows:
About 80% of individuals with type 1 AIP have painless jaundice, which is brought on by obstructed bile ducts. Recurrent episodes of acute pancreatitis can be observed in Type 2 AIP. Unlike pancreatic cancer, the presence of upper abdominal pain, which is a typical symptom, is often lacking in cases of autoimmune pancreatitis.
There are some differences between type 1 and type 2 AIP: (1 all)
The symptoms of autoimmune pancreatitis are frequently undetectable. However, if the patient experiences troublesome signs and symptoms such as unexplained weight loss, stomach pain, or jaundice, they should consult a healthcare provider.
The cause of autoimmune pancreatitis is unknown, but like other autoimmune disorders, it is assumed to be brought on by the body’s immune system attacking healthy bodily tissue.
In certain instances, autoimmune pancreatitis can arise as a result of the immune system’s reaction following a bacterial infection. Moreover, individuals with existing autoimmune disorders are at an increased risk. The frequency of the two types of AIP varies across different regions worldwide. In the United States, approximately 80 percent of individuals diagnosed with autoimmune pancreatitis have type 1.
+66 2066 8888